ACTA1 and Hepatic fibrosis: Meanwhile, treatment by CHR–HPBCD and CHR–RAMEB considerably decreased α-SMA gene expression in CCl4-induced liver fibrosis mice, whereas free chrysin had lower protection (Figure 3).